Please note that maintenance work is scheduled between 4 AM and 5 AM - CET.
During this time, you may experience reduced performance.
Thanks for your patience.
in (world ranking)
Vladan Vucinic
Hematology — University Hospital Leipzig, Germany
Vladan Vucinic
Joined Oct 2026
University Hospital Leipzig · Hematology
Top 1% Worldwide expert in CAR-T Cell, Lymphoproliferative Disorders, Lymphoma, T-Lymphocytes
A Phase 1 Study of CD19 targeted NEX T CAR T Cells in Participants with Severe Refractory Autoimmune Diseases (Breakfree 1) 2023-503823-24-01 — cells, autoimmune diseases, car-t cell
Phase 1
Active not recruiting
2024
CAR T cell treatment for untreated high risk MANtle Cell Lymphoma 2022-502405-15-01 — cells, lymphoma, maintenance, rituximab, lymphoma, mantle-cell, therapeutics, t-lymphocytes, car-t cell
Phase 2
Recruiting
2024
Study of CC 97540 (BMS 986353) CD19 CAR T Cells in Participants with Active SLE Despite Immunosuppressants (Breakfree SLE) 2024-519278-37-00 — cells, glucocorticoids, lupus nephritis, immunosuppressive agents, lupus erythematosus, systemic, nephritis, car-t cell
Phase 2
Active not recruiting
2025
PIRTOBRUTINIB AND GLOFITAMAB IN MANTLE CELL LYMPHOMA 2024-512922-27-00 — cells, lymphoma, aged, lymphoma, mantle-cell, therapeutics
Phase 2
Recruiting
2025
A Phase II Open Label Single Center Single Arm Pilot Study to Evaluate the Safety Tolerability and Efficacy of Blinatumomab for Treatment of Patients with Autoimmune B Cell driven Diseases including Systemic Lupus Erythematosus (SLE) Systemic Sclerosis (SSc) and Granulomatous Polyangiitis (GPA) BlinA B trial 2025-523061-22-00 — pilot projects, cells, sclerosis, pilots, safety, lupus erythematosus, systemic, therapeutics, b-lymphocytes, scleroderma, systemic
To provide the best experience, we use technologies such as cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent or withdrawal of consent may adversely affect certain features and functions.
Functional
Always active
Storage or technical access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of transmitting a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
Storage or technical access used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles in order to send advertisements, or to track the user on a website or on several websites with similar marketing purposes.